The pharmaceutical industry seems besieged on all sides, with declining R&D productivity, expiring patents on blockbuster products and relentless downward pricing pressure forcing companies to look closely at the bottom line. One affect of this onslaught has been an upsurge in the level of M&A activity as players within the industry consolidate to cut costs, expand research pipelines and lengthen geographic reach.
25-Aug-2011 - US chemicals maker Ashland says completion of ISP takeover means simplified supply chains for drug and cosmetics industry customers.
10-Aug-2011 - Akela Pharma is focusing on its CMO and expanding it through acquisitions after its partner exited their drug development programme.
08-Aug-2011 - International Chemical Investors Group (ICIG) will take over Roche’s Colorado API plant in a bid to gain footing in the peptide manufacturing industry.
20-Jul-2011 - Filtration, separation and purification technology company Pall is to acquire its long-time Brazilian distribution partner, Engefiltro.
19-Jul-2011 - Granules and Ajinomoto OmniChem have teamed up to produce high value APIs and intermediates at a new Indian plant.
06-Jul-2011 - Gerresheimer is interested in a US acquisition as part of a bid to build in the North American plastic drug packaging sector.
27-Jun-2011 - BioMarin will buy Pfizer’s biologics manufacturing plant in Shanbally, Cork, Ireland to add production capacity for its candidate mucopolysaccharidosis treatment.
14-Jun-2011 - GlaxoSmithKline (GSK) has announced plans to buy its joint venture Shenzhen GSK Neptunus Biologicals (GSKNB) to expand influenza vaccine production capacity in China.
09-Jun-2011 - Portugal-headquartered API manufacturer Hovione has teamed up with Particle Sciences (PSI) to tackle the issue of poor drug solubility.
01-Jun-2011 - Ashland will buy International Specialty Products (ISP) in a deal designed to expand it's business in less cyclical, high-growth markets such as pharmaceuticals and personal care.
31-May-2011 - Watson Pharmaceuticals has bought Greek generics firm Specifar Pharmaceuticals, bringing to an end a busy month of deal making in the non-branded drug sector.
18-May-2011 - UK-based drugmaker Shire has unveiled plans to buy Advanced BioHealing (ABH) citing the lack of generic competition in the regenerative medicines sector as a factor.
11-May-2011 - Aurobindo Pharma is considering demerging its API and formulation businesses to unlock value and better serve clients.
09-May-2011 - Elan will sell its delivery technology unit, EDT, to Alkermes in a deal that brings to an end the Irish drugmakers’ long search for a buyer.
28-Apr-2011 - Switzerland – based specialty chemicals group Clariant has acquired 96.15 per cent of German Süd – Chemie.
27-Apr-2011 - Oystar has sold its processing tech units, Huttlin and Manesty, to Bosch in a deal that continues its effort to refocus on primary and secondary packaging.
18-Apr-2011 - MENA-focused drug manufacturer, Hikma, has entered into a strategic partnership with Indian API and intermediates business, Unimark Remedies.
12-Apr-2011 - Nano Terra, a surface engineering and nanotechnology company based in Brighton Massachusetts, US, has struck a deal to acquire neighbouring drug developer, Surface Logix.
05-Apr-2011 - Pharmaceutical giant Pfizer has agreed to sell Capsugel, its drug delivery technology unit, to US investment group Kohlberg Kravis Roberts & Co (KKR) for $2.4bn (€1.7bn).
05-Apr-2011 - Processing and packaging technology firm Romaco will be sold to German private equity group Deutsche Beteiligungs AG (DBAG) for €61m (£86.5m).
28-Mar-2011 - Sigma Pharmaceuticals posted a A$235.4m (€172.0m) loss in 2010 but its share value soared on payment of a special dividend.
23-Mar-2011 - Gerresheimer has bought Brazilian pharmaceutical plastic packaging maker Vedat, citing rapid growth of the country’s drug market, particularly the generics segment, as the main driver for the acquisition.
02-Mar-2011 - Clondalkin is to buy the printed components unit from Catalent as part of an ongoing acquisition strategy in the strong sector growth.
28-Feb-2011 - Tokyo, Japan-based digital imaging specialist, Fujifilm, has agreed a deal to buy US drug giant Merck and Co's BioManufacturing Network, including two biotech manufacturing plants.
22-Feb-2011 - Belgian chemicals distributor Azelis has agreed to buy S&D Group citing its presence in key pharmaceutical ingredients markets as an important driver.